Published in Br J Pharmacol on November 01, 1980
Evidence against the unitary hypothesis of agonist and antagonist action at presynaptic adrenoceptors. Br J Pharmacol (1982) 1.07
Prejunctional beta-adrenoceptors in rabbit pulmonary artery and mouse atria: effect of alpha-adrenoceptor blockade and phosphodiesterase inhibition. Br J Pharmacol (1986) 0.94
The role of calcium in the effects of noradrenaline and phenoxybenzamine on adrenergic transmitter release from atria: no support for negative feedback of release. Br J Pharmacol (1981) 0.94
The physiological and pharmacological role of presynaptic alpha- and beta-adrenoceptors in man. Br J Clin Pharmacol (1985) 0.91
Presynaptic beta-adrenoceptors in rat atria: evidence for the presence of stereoselective beta 1-adrenoceptors. Br J Pharmacol (1989) 0.75
Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol (1977) 7.62
Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmacol (1977) 6.01
Dibenamine blockade in strips of rabbit aorta and its use in differentiating receptors. J Pharmacol Exp Ther (1954) 4.36
Local regulation of adrenergic neurotransmission. Physiol Rev (1977) 2.63
The effect of a saturable uptake mechanism on the slopes of dose-response curves for sympathomimetic amines and on the shifts of dose-response curves produced by a competitive antagonist. J Pharmacol Exp Ther (1969) 2.48
Possible role of a beta-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism. Br J Pharmacol (1975) 1.84
The sensitivity of the guinea-pig pacemaker to norepinephrine and calcium after pretreatment with reserpine. J Pharmacol Exp Ther (1968) 1.60
Beta2-adrenoceptors facilitating noradrenaline secretion from human vasoconstrictor nerves. Acta Physiol Scand (1976) 1.57
Mode of action of beta receptor antagonists on cardiac muscle. Am J Cardiol (1966) 1.52
Selectivity for catecholamines of presynaptic alpha-receptors involved in feedback control of sympathetic neurotransmitter secretion in guinea-pig vas deferens. Naunyn Schmiedebergs Arch Pharmacol (1975) 1.36
Adrenergic receptors in the veins of the dog. Eur J Pharmacol (1969) 1.30
Single pulse stimulation of guinea-pig vas deferens and the presynaptic receptor hypothesis. Br J Pharmacol (1979) 1.27
Role of adrenergic neurone blockade in the hypotensive action of propranolol. Br J Pharmacol (1971) 1.25
Beta-receptors in human isolated smooth muscle. Br J Pharmacol (1969) 1.24
Limitations of presynaptic adrenoceptor theory: the characteristics of the effects of noradrenaline and phenoxybenzamine on stimulation-induced efflux of [3H]noradrenaline in vas deferens. J Pharmacol Exp Ther (1980) 1.23
Adrenergic antagonists and the presynaptic receptor hypothesis in vascular tissue. J Pharmacol Exp Ther (1979) 1.21
Adrenergic presynaptic receptors: examination of a hypothesis in guinea pig vas deferens. Can J Physiol Pharmacol (1979) 1.18
Presynaptic receptor systems on the noradrenergic neurones of the rabbit pulmonary artery. Naunyn Schmiedebergs Arch Pharmacol (1977) 1.16
Dissociation of the supersensitivity to norepinephrine caused by cocaine from inhibition of H3-norepinephrine uptake in cold-stored smooth muscle. J Pharmacol Exp Ther (1969) 1.15
An examination of the negative feedback function of presynaptic adrenoceptors in a vascular tissue. Br J Pharmacol (1979) 1.13
Cerebral arterial spasm. 1. In vitro contractile activity of vasoactive agents on canine basilar and middle cerebral arteries. J Neurosurg (1974) 1.11
Interactions of bretylium and other drugs on guinea-pig atria: evidence for inhibition of neuronal monoamine oxidase by bretylium. J Pharmacol Exp Ther (1971) 1.11
Effects of inhibition of monoamine oxidase on the actions and interactions of norepinephrine, tyramine and other drugs on guinea-pig left atrium. J Pharmacol Exp Ther (1968) 1.09
Adrenergic neuron blocking properties of (plus or minus)-propranolol and (plus)-propranolol. J Pharm Pharmacol (1970) 1.08
Selective blockade of potassium-induced contractions of aortic strips by beta-diethylaminoethyl-diphenylpropylacetate (SKF 525A). J Pharmacol Exp Ther (1970) 0.98
The potentiation of rat uterine inhibitory responses to noradrenaline by theophylline and nitroglycerine. Br J Pharmacol (1968) 0.97
Mechanism of methylxanthine sensitization of norepinephrine responses in a coronaryartery. Am J Physiol (1975) 0.96
DIFFERENT TYPES OF SYMPATHOMIMETIC ALPHA-RECEPTORS. J Pharm Pharmacol (1965) 0.93
Effects of cocaine on the rate of contraction to noradrenaline in the cat spleen strip: mode of action of cocaine. Br J Pharmacol Chemother (1968) 0.93
Stimulation of presynaptic beta-adrenoceptors enhances [3H]-noradrenaline release druing nerve stimulation in the perfused cat spleen. Br J Pharmacol (1978) 0.92
The presence of antagonistically acting alpha and beta adrenergic receptors in the mouse spleen. J Pharmacol Exp Ther (1968) 0.91
Further studies on the adrenergic neuron blocking activity of some -adrenoceptor antagonists and guanethidine. J Pharm Pharmacol (1973) 0.89
Adrergic receptors in the guinea pig trachea and lung. Acta Pharmacol Toxicol (Copenh) (1970) 0.88
Influence of alpha- and beta-adrenoceptors on the release of noradrenaline from field stimulated atria and cerebral cortex slices. J Pharm Pharmacol (1974) 0.88
Noradrenaline inhibition of transmitter efflux in a renal artery preparation and the presynaptic receptor theory. Can J Physiol Pharmacol (1979) 0.86
The role of alpha- and beta-presynaptic receptors in the regulation of noradrenaline release elicited by nerve stimulation. Clin Sci Mol Med Suppl (1976) 0.83
Mechanisms of inactivation of noradrenaline in the iris sphincter, tracheal muscle and facial artery of cattle: implications for beta-adrenoceptor-mediated responses. Br J Pharmacol (1978) 0.81
The bimodal basis of the contractile response of the rabbit ear artery to norepinephrine and other agonists. Eur J Pharmacol (1973) 0.79
A receptor kinetic model of a vascular neuroeffector. J Pharmacol Exp Ther (1972) 0.79
The slopes of cumulative and non-cumulative dose--response curves for noradrenaline and isoprenaline. Eur J Pharmacol (1972) 0.77
Anti-arrhythmic, local anaesthetic, and adrenergic blocking activity of some beta-receptor antagonists. Br J Pharmacol (1969) 0.77
Decrease in ionic permeability of the cell membrane in guinea-pig atrial tissue by treatment with antifibrillatory agents and hexobarbitone, determined by means of 86Rb. Br J Pharmacol (1969) 0.77
Blockade of catecholamine mediated release of free fatty acids from adipose tissue in vitro. Arch Int Pharmacodyn Ther (1967) 0.76
Mechanism of hydrocortisone potentiation of responses to epinephrine and norepinephrine in rabbit aorta. Circ Res (1969) 2.53
Steroid potentiation of responses to sympathomimetic amines in aortic strips. Br J Pharmacol (1969) 1.90
Mechanism of cocaine potentiation of responses to amines. Br J Pharmacol (1969) 1.78
Effects of a haloalkylamine on responses to and disposition of sympathomimetic amines. Br J Pharmacol (1969) 1.43
Disposition of norepinephrine and epinephrine in vascular tissue, determined by the technique of oil immersion. J Pharmacol Exp Ther (1969) 1.35
A method for the study of mechanisms of drug disposition in smooth muscle. Can J Physiol Pharmacol (1968) 1.28
Cholinergic mechanisms in human coronary artery preparations: implications of species differences. J Physiol (1985) 1.28
Single pulse stimulation of guinea-pig vas deferens and the presynaptic receptor hypothesis. Br J Pharmacol (1979) 1.27
Limitations of presynaptic adrenoceptor theory: the characteristics of the effects of noradrenaline and phenoxybenzamine on stimulation-induced efflux of [3H]noradrenaline in vas deferens. J Pharmacol Exp Ther (1980) 1.23
Adrenergic antagonists and the presynaptic receptor hypothesis in vascular tissue. J Pharmacol Exp Ther (1979) 1.21
Coronary arteries of cardiac patients are hyperreactive and contain stores of amines: a mechanism for coronary spasm. Science (1984) 1.21
Adrenergic presynaptic receptors: examination of a hypothesis in guinea pig vas deferens. Can J Physiol Pharmacol (1979) 1.18
Coronary artery reactivity in human vessels: some questions and some answers. Fed Proc (1985) 1.13
An examination of the negative feedback function of presynaptic adrenoceptors in a vascular tissue. Br J Pharmacol (1979) 1.13
Disposition of phenylephrine in vascular tissue, determined by the oil-immersion technique. J Pharmacol Exp Ther (1968) 1.11
A new approach to the measurement and classification of forms of supersensitivity of autonomic effector responses. Br J Pharmacol (1974) 1.10
Intrinsic prostaglandin release. A mediator of anoxia-induced relaxation in an isolated coronary artery preparation. Blood Vessels (1976) 1.08
Evidence against the unitary hypothesis of agonist and antagonist action at presynaptic adrenoceptors. Br J Pharmacol (1982) 1.07
Role of extraneuronal mechanisms in the termination of contractile responses to amines in vascular tissue. Br J Pharmacol (1975) 1.06
Adrenergic presynaptic recpetors: an overextended hypothesis? J Pharm Pharmacol (1980) 1.02
Selective blockade of potassium-induced contractions of aortic strips by beta-diethylaminoethyl-diphenylpropylacetate (SKF 525A). J Pharmacol Exp Ther (1970) 0.98
Inhibition by dopamine of the stimulation-induced efflux of [3H]noradrenaline in renal arteries: limitations of the unitary hypothesis of presynaptic regulation of transmitter release. Can J Physiol Pharmacol (1980) 0.98
Mechanism of methylxanthine sensitization of norepinephrine responses in a coronaryartery. Am J Physiol (1975) 0.96
Effects of reserpine on the disposition of sympathomimetic amines in vascular tissue. Br J Pharmacol (1969) 0.95
The role of calcium in the effects of noradrenaline and phenoxybenzamine on adrenergic transmitter release from atria: no support for negative feedback of release. Br J Pharmacol (1981) 0.94
Yohimbine and prolongation of stimulation pulse duration alter similarly 3H-transmitter efflux in heart: an alternative to the negative feedback hypothesis. Br J Pharmacol (1983) 0.94
Mechanism of potentiation of contractor responses to catecholamines by methylxanthines in aortic strips. Br J Pharmacol (1971) 0.93
Effects of the inhibition of noradrenaline uptake and synthesis on the maintenance of the response to continuous nerve stimulation in the central artery of the rabbit ear. Br J Pharmacol (1972) 0.92
Sensitization of noradrenaline responses by inhibitors of extraneuronal uptake in a coronary artery preparation. Br J Pharmacol (1974) 0.92
Adenosine and dipyridamole actions and interactions on isolated coronary artery strips of cattle. Br J Pharmacol (1975) 0.90
Potentiation of responses to histamine in aortic strips by steroids. Can J Physiol Pharmacol (1970) 0.90
[Letter: The importance of adrenergic neuronal uptake in termination of action; another view. Response to i. s. de la lande]. Blood Vessels (1975) 0.88
Endogenous prostaglandin release contributes directly to coronary artery tone. Can J Physiol Pharmacol (1975) 0.87
A hypothesis to explain the presynaptic effects of adrenoceptor antagonists. Br J Pharmacol (1984) 0.87
The effects of yohimbine on presynaptic and postsynaptic events during sympathetic nerve activation in cattle iris: a critique of presynaptic receptor theory. Br J Pharmacol (1983) 0.87
Enhancement of the alpha receptor blocking action of N-ethoxycarbonyl-2--ethoxy-1,2-dihydroquinoline (EEDQ) by amines. Life Sci I (1970) 0.86
Noradrenaline inhibition of transmitter efflux in a renal artery preparation and the presynaptic receptor theory. Can J Physiol Pharmacol (1979) 0.86
The potentiating effects of ethanol on response of aortic strips to stimulant drugs. J Pharm Pharmacol (1970) 0.85
Sensitization of effector responses by modification of agonist disposition mechanisms. Can J Physiol Pharmacol (1976) 0.83
The effect of hypoxia on prostaglandin output and on tone in isolated coronary arteries. Can J Physiol Pharmacol (1977) 0.82
Effects of tyramine on responses to and inactivation of histamine in aortic strips. J Pharmacol Exp Ther (1970) 0.82
The effects of periarterial nerve activation on coronary vessel tone in an isolated and perfused slab of beef ventricle. Can J Physiol Pharmacol (1979) 0.81
Evidence that transmitter release in sympathetic nerves is not set by feedback via presynaptic receptors. Can J Physiol Pharmacol (1983) 0.81
Mechanisms of inactivation of noradrenaline in the iris sphincter, tracheal muscle and facial artery of cattle: implications for beta-adrenoceptor-mediated responses. Br J Pharmacol (1978) 0.81
A vasodilator innervation to the central artery of the rabbit ear. Br J Pharmacol (1974) 0.81
One trial learning in the mouse. I. Its characteristics and modification by experimental-seasonal variables. Psychopharmacologia (1968) 0.81
Positive feedback regulation of noradrenaline release from sympathetic nerves: a questionable hypothesis. Can J Physiol Pharmacol (1982) 0.81
Mechanism of potentiation of vascular responses by tetraethylammonium: a novel form of sensitization. Can J Physiol Pharmacol (1973) 0.80
Differential activation of the inner and outer muscle cell layers of the rabbit ear artery. Eur J Pharmacol (1972) 0.79
Termination of effector responses to agonists: an analysis of agonist disposition mechanisms. Can J Physiol Pharmacol (1977) 0.79
Mechanism of potentiation by amines of non-equilibrium blockade of the alpha-adrenoceptor. Br J Pharmacol (1973) 0.79
Limitations of presynaptic theory: no support for feedback control of autonomic effectors. Fed Proc (1984) 0.78
Potentiation of responses to and inhibition of extraneuronal metabolism of catecholamines by veratrine. J Pharm Pharmacol (1972) 0.78
Termination of responses to sympathetic nerve stimulation and to noradrenaline in a perfused arterial preparation: the role of neuronal and extraneuronal uptake. J Pharmacol Exp Ther (1982) 0.78
A coronary vasoconstrictor substance is present in regular and "decaffeinated" forms of both percolated and instant coffee. Life Sci (1977) 0.78
Clonidine and presynaptic adrenoceptor theory. Br J Pharmacol (1985) 0.77
Is there feedback regulation of neurotransmitter release by autoreceptors? Biochem Pharmacol (1985) 0.76
High-dose epinephrine in cardiopulmonary resuscitation. N Engl J Med (1993) 0.75
Circadian variation in vascular tone. N Engl J Med (1992) 0.75
The lack of effect of oxytetracycline on responses to sympathetic nerve stimulation and catecholamines in vascular tissue. Br J Pharmacol (1976) 0.75
The effect of magnesium deficiency and excess on bovine coronary artery tone and responses to agonists. Br J Pharmacol (1983) 0.75
Sympathetic-nerve activity during sleep. N Engl J Med (1993) 0.75
With TIAs, MDs cannot rely on patients to provide a meaningful history. CMAJ (1990) 0.75
Investigation of a possible interaction between propranolol and a nitrite on coronary artery tone. Can J Physiol Pharmacol (1974) 0.75
Responses to noradrenaline and potassium, and disposition of noradrenaline in aortic strips of desoxycorticosterone acetate--NaCl hypertensive rabbits. Can J Physiol Pharmacol (1971) 0.75
Increased monoamine oxidase activity in cardiovascular and central nervous systems of DOCA-NaCl hypertensive rabbits. Life Sci (1977) 0.75
Responses to and termination of action of prostaglandins in vascular tissue of the rabbit. Can J Physiol Pharmacol (1974) 0.75
Prostaglandin mediated relaxation of coronary artery strips under hypoxia. Prostaglandins Med (1978) 0.75